Advancing therapy for neuroblastoma

B Qiu, KK Matthay - Nature Reviews Clinical Oncology, 2022 - nature.com
Neuroblastomas are tumours of sympathetic origin, with a heterogeneous clinical course
ranging from localized or spontaneously regressing to widely metastatic disease …

Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the …

RL Mulder, A Font-Gonzalez, MM Hudson… - The Lancet …, 2021 - thelancet.com
Female patients with childhood, adolescent, and young adult cancer are at increased risk for
fertility impairment when treatment adversely affects the function of reproductive organs …

Overview and recent advances in the treatment of neuroblastoma

SB Whittle, V Smith, E Doherty, S Zhao… - Expert review of …, 2017 - Taylor & Francis
Introduction: Children with neuroblastoma have widely divergent outcomes, ranging from
cure in> 90% of patients with low risk disease to< 50% for those with high risk disease …

Neuroblastoma: paradigm for precision medicine

MS Irwin, JR Park - Pediatric Clinics, 2015 - pediatric.theclinics.com
Neuroblastoma (NB), the most common extracranial tumor of childhood, is a cancer of
primordial neural crest cells that give rise to sympathetic neural ganglia and adrenal …

CAR T cell therapy for neuroblastoma

RM Richards, E Sotillo, RG Majzner - Frontiers in immunology, 2018 - frontiersin.org
Patients with high risk neuroblastoma have a poor prognosis and survivors are often left with
debilitating long term sequelae from treatment. Even after integration of anti-GD2 …

Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With …

NKV Cheung, IY Cheung, BH Kushner… - Journal of clinical …, 2012 - ascopubs.org
Purpose Anti-GD2 monoclonal antibody (MoAb) combined with granulocyte-macrophage
colony-stimulating factor (GM-CSF) has shown efficacy against neuroblastoma (NB) …

MYCN impact on high-risk neuroblastoma: from diagnosis and prognosis to targeted treatment

D Bartolucci, L Montemurro, S Raieli, S Lampis… - Cancers, 2022 - mdpi.com
Simple Summary Neuroblastoma is one of the most diffuse and the deadliest cancer in
children. While many advances have been made in the last few decades to improve patients' …

Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review

A Overbeek, MH van den Berg, FE van Leeuwen… - Cancer treatment …, 2017 - Elsevier
Background Anti-cancer treatment may reduce the fertile life span and induce premature
menopause. This review aims to provide an overview of the available literature on effects of …

Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study

JM Levine, JA Whitton, JP Ginsberg, DM Green… - Cancer, 2018 - Wiley Online Library
BACKGROUND Survivors of childhood cancer are at risk of nonsurgical premature
menopause (NSPM). To the authors' knowledge, risk factors for NSPM and its impact on …

Treatment and survival of childhood neuroblastoma: evidence from a population-based study in the United States

D Coughlan, M Gianferante, CF Lynch… - Pediatric hematology …, 2017 - Taylor & Francis
Background: Childhood neuroblastoma describes a heterogeneous group of extracranial
solid tumors, that are treated per risk profile. We sought to describe treatment patterns and …